The US Food and Drug Administration is advising extra precautions after seizing thousands of units of counterfeit Ozempic, according to a notice issued Thursday.
The agency said the counterfeit drugs have been linked to five cases of illness so far, but none have been described as serious. People who used counterfeit supplements have reported adverse reactions consistent with the authentic product, including nausea, vomiting, diarrhea, stomach pain and constipation.
While the FDA and Ozempic’s manufacturer, Novo Nordisk, have already collected thousands of samples and are testing them, they warn that some counterfeit products may still be available for purchase.
Because of this, wholesalers, retail pharmacies, health care practitioners, and patients alike are advised to check any semaglutide they receive to ensure that they are not part of a fraudulent supply known as lot number NAR0074. And labeled with serial number 430834149057.
Celebs and Ozempic:Oprah Winfrey’s revelation about using weight loss drugs is a game changer. here’s why.
Keep an eye out for counterfeit items
The FDA and Novo Nordisk are currently testing the collected samples to determine their content, safety and efficacy. So far, they have determined that the products’ pen labels, health care professional and patient information, and the carton the drug comes in were all counterfeit.
Importantly, the needles were also found to be counterfeit, meaning their sterility could not be confirmed and could put patients at increased risk of infection.
Anyone currently possessing a semaglutide product is advised to look closely before using, selling, or otherwise distributing it to confirm not only the lot and serial number, but also the labeling and packaging it comes in. The FDA encourages consumers to compare photos. Authentic Ozempic packaging for products in their supply posted on their website accounts for differences in color, label, and overall appearance.
The agency also reminded pharmacies to purchase Ozempic only through authorized Novo Nordisk distributors and for patients to obtain it only through a prescription from a state-licensed pharmacy. Every person handling the product is advised to inspect it carefully for signs of tampering or counterfeiting.
What is Ozempic (semaglutide)?
What is Ozempic:You’ve heard of Ozempic, but do you understand how it works?
Weight loss drugs become one of the hottest topics in health in 2023. Originally intended to manage diabetes, the most popular drug, semaglutide, has gained massive popularity for its ability to promote quick weight loss in patients.
Semaglutide is the generic name for Vegovy, which is approved for weight loss, and Ozempic, which is used to treat diabetes. Both are made by Novo Nordisk.
Ozempic works by mimicking the hormone GLP-1, which helps the pancreas release insulin. It promotes weight loss by sending signals to the hunger center in your brain to reduce hunger and increase satiety, thereby managing hunger signals, sticking to smaller and smaller meals, and overcoming emotional or boredom eating. It becomes easy.
Semaglutide has been shown to help patients lose 15% to 20% of their body weight, but it is also expensive and is often not covered by insurance when used for weight loss purposes.
Costing about $1,000 per month for weekly injections, the drugs have also been shown to have some serious downsides, one of which is the tendency for consumers to gain weight again after stopping treatment. The risk of pancreatitis, gallstone disease and gastroparesis is also reduced.
Semaglutide has been in short supply for about two years, primarily because it is being prescribed off-label to people who do not have diabetes.
While Ozempic was approved to treat diabetes in 2017, Vegov was only approved for use in weight loss in 2021, leading to an explosion in demand.
As previously reported by USA TODAY, Novo Nordisk has struggled to meet overwhelming demand, as data released in September showed that prescriptions skyrocketed in major metropolitan areas within the first year of Wegovi’s approval. Went. In some places like Cleveland and Seattle, prescriptions for semaglutide increased by 481% and 351%, respectively.
#Fake #Ozempic #warning #issued #FDA #seizes #thousands #units
Image Source : www.usatoday.com